Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.
drugs
erythema
flushing
lasers
lifestyle
management
ocular
papules
phenotypes
phymatous
pustules
rosacea
telangiectasia
therapy
utility
Journal
Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
20
02
2019
revised:
24
10
2019
accepted:
31
01
2020
pubmed:
10
2
2020
medline:
22
1
2021
entrez:
10
2
2020
Statut:
ppublish
Résumé
In 2017, a National Rosacea Society Expert Committee developed and published an updated classification of rosacea to reflect current insights into rosacea pathogenesis, pathophysiology, and management. These developments suggest that a multivariate disease process underlies the various clinical manifestations of the disorder. The new system is consequently based on phenotypes that link to this process, providing clear parameters for research and diagnosis as well as encouraging clinicians to assess and treat the disorder as it may occur in each individual. Meanwhile, a range of therapies has become available for rosacea, and their roles have been increasingly defined in clinical practice as the disorder has become more widely recognized. This update is intended to provide a comprehensive summary of management options, including expert evaluations, to serve as a guide for tailoring treatment and care on an individual basis to achieve optimal patient outcomes.
Identifiants
pubmed: 32035944
pii: S0190-9622(20)30166-3
doi: 10.1016/j.jaad.2020.01.077
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1501-1510Informations de copyright
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.